SI0959888T1 - Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease - Google Patents
Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's diseaseInfo
- Publication number
- SI0959888T1 SI0959888T1 SI9730230T SI9730230T SI0959888T1 SI 0959888 T1 SI0959888 T1 SI 0959888T1 SI 9730230 T SI9730230 T SI 9730230T SI 9730230 T SI9730230 T SI 9730230T SI 0959888 T1 SI0959888 T1 SI 0959888T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pharmaceutical composition
- alzheimer
- disease
- manufacture
- treatment
- Prior art date
Links
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005228 clioquinol Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 239000002738 chelating agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR96100286 | 1996-08-13 | ||
PCT/IB1997/000983 WO1998006403A1 (en) | 1996-08-13 | 1997-08-08 | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
EP97932969A EP0959888B1 (en) | 1996-08-13 | 1997-08-08 | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0959888T1 true SI0959888T1 (en) | 2002-10-31 |
Family
ID=10942479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9730230T SI0959888T1 (en) | 1996-08-13 | 1997-08-08 | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
Country Status (26)
Country | Link |
---|---|
US (1) | US6001852A (ru) |
EP (1) | EP0959888B1 (ru) |
JP (1) | JP2000516606A (ru) |
KR (1) | KR100489969B1 (ru) |
CN (1) | CN1114407C (ru) |
AT (1) | ATE205086T1 (ru) |
AU (1) | AU720643B2 (ru) |
BR (1) | BR9711194A (ru) |
CA (1) | CA2264097C (ru) |
CZ (2) | CZ295118B6 (ru) |
DE (1) | DE69706566T2 (ru) |
DK (1) | DK0959888T3 (ru) |
ES (1) | ES2162319T3 (ru) |
HK (1) | HK1022437A1 (ru) |
HU (1) | HUP9903906A3 (ru) |
IL (1) | IL128416A (ru) |
IS (1) | IS1907B (ru) |
NO (1) | NO316768B1 (ru) |
NZ (1) | NZ334124A (ru) |
PL (1) | PL188838B1 (ru) |
PT (1) | PT959888E (ru) |
RU (1) | RU2193406C2 (ru) |
SI (1) | SI0959888T1 (ru) |
SK (1) | SK283117B6 (ru) |
TR (1) | TR199900293T2 (ru) |
WO (1) | WO1998006403A1 (ru) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
EA002526B1 (ru) * | 1997-08-21 | 2002-06-27 | П.Н.Геролиматос С.А. | Применение фанхинона для лечения болезни альцгеймера |
ATE555780T1 (de) * | 1997-10-24 | 2012-05-15 | John P Blass | Nahrungsergänzungsmittel für metabolische hirnleistungsstörungen |
US5994323A (en) * | 1997-12-31 | 1999-11-30 | P.N. Gerolymatos S.A. | Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof |
US20020025944A1 (en) * | 2000-04-28 | 2002-02-28 | Bush Ashley I. | Use of clioquinol for the therapy of Alzheimer's disease |
US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
US6323218B1 (en) * | 1998-03-11 | 2001-11-27 | The General Hospital Corporation | Agents for use in the treatment of Alzheimer's disease |
US20050112543A1 (en) * | 1998-03-11 | 2005-05-26 | The General Hospital Corporation | Method of screening for drugs useful in treating Alzheimer's disease |
DK1140090T3 (da) | 1999-01-07 | 2005-04-18 | Gerolymatos P N Sa | Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt |
US6692234B2 (en) | 1999-03-22 | 2004-02-17 | Water Management Systems | Pump system with vacuum source |
AU2001230584A1 (en) * | 2000-02-09 | 2001-08-20 | Hokuriku Seiyaku Co., Ltd. | 1h-imidazopyridine derivatives |
FR2818551B1 (fr) * | 2000-12-22 | 2007-06-01 | Claude Marc Pierre Hannoun | Utilisation de chelateurs pour le traitement des maladies a prions |
US6803379B2 (en) * | 2002-06-04 | 2004-10-12 | Jose A. Fernandez-Pol | Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
AU2002950217A0 (en) | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
US7692011B2 (en) | 2002-10-04 | 2010-04-06 | Prana Biotechnology Limited | 8-hydroxy and 8-mercapto quinazolinones |
US20080063599A1 (en) * | 2002-11-18 | 2008-03-13 | Jorge Setoain Quinquer | Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils |
EP1617844A4 (en) * | 2003-04-03 | 2009-07-22 | Prana Biotechnology Ltd | TREATMENT OF NEUROLOGICAL DISEASES |
JP2007511544A (ja) * | 2003-11-19 | 2007-05-10 | アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド | アミロイド症の予防若しくは治療のための組成物および方法 |
US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
US8871715B2 (en) | 2005-10-14 | 2014-10-28 | Alltech, Inc. | Use of selenium compounds, especially selenium yeasts for altering cognitive function |
US8865763B2 (en) | 2005-10-14 | 2014-10-21 | Alltech, Inc. | Methods and compositions for altering cell function |
TWI319708B (en) * | 2005-10-14 | 2010-01-21 | Methods and compositions for altering cell fuction | |
KR20080090408A (ko) * | 2005-11-30 | 2008-10-08 | 아보트 러보러터리즈 | 항-Aβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법 |
CN102225930A (zh) * | 2006-04-14 | 2011-10-26 | 普拉纳生物技术有限公司 | 治疗与年龄相关的黄斑变性(amd)的方法 |
TWI551607B (zh) * | 2006-07-14 | 2016-10-01 | Ac免疫公司 | 人類化抗體 |
SI2468770T1 (en) * | 2006-07-14 | 2018-05-31 | Ac Immune S.A. | A humanized antibody against amyloid beta. |
US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
PT2238166E (pt) | 2007-10-05 | 2014-02-11 | Genentech Inc | Utilização do anticorpo anti-amilóide beta em doenças oculares |
ES2332687B1 (es) * | 2008-03-13 | 2011-01-10 | Proyecto De Biomedicina Cima, S.L. | Nuevos usos de 4pba y sus sales farmaceuticamente aceptables. |
RU2607368C2 (ru) | 2010-07-30 | 2017-01-10 | Ац Иммуне С.А. | Безопасные и функциональные гуманизированные антитела |
FR2966827B1 (fr) | 2010-10-27 | 2014-08-22 | Kimonella Ventures Ltd | Compose peptidique utile pour l'inhibition de la formation de plaques amyloides |
JP6153179B2 (ja) * | 2013-04-02 | 2017-06-28 | アンジー ファーマスーティカル シーオー.,エルティーディー.Annji Pharmaceutical Co., Ltd. | 抗神経変性剤としての多機能キノリン誘導体 |
EP4039255A1 (en) | 2014-04-24 | 2022-08-10 | Omoidesouzou Co. Ltd. | Amyloid fiber formation limiter or inhibitor |
KR20160057500A (ko) * | 2014-11-05 | 2016-05-24 | 아카데미아 시니카 | 클리오퀴놀을 포함하는 자폐증 스펙트럼 장애의 치료용 약학적 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3174899A (en) * | 1960-12-30 | 1965-03-23 | Ciba Geigy Corp | Composition for the management of post antibiotic enteritis |
US3178343A (en) * | 1962-11-27 | 1965-04-13 | Ciba Geigy Corp | Pharmaceutical compositions and method of using same |
DE1617417A1 (de) * | 1966-12-08 | 1971-03-25 | Ciba Geigy | Pharmazeutisches Praeparat |
DE3932338A1 (de) * | 1989-09-28 | 1991-04-11 | Nmi Naturwissenschaftl U Mediz | Verfahren zur praeventiven therapie von morbus alzheimer |
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
GB9108080D0 (en) * | 1991-04-15 | 1991-06-05 | Smithkline Beecham Plc | Pharmaceutical composition |
US5206264A (en) * | 1991-11-04 | 1993-04-27 | Cypros Pharmaceutical Corporation | Use of disulfiram to prevent cardiovascular damage |
JP3277211B2 (ja) * | 1991-11-12 | 2002-04-22 | プラナ・バイオテクノロジー・リミテッド | アルツハイマー病の試験方法と治療方法 |
US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
AU1831195A (en) * | 1994-01-13 | 1995-08-01 | Research Foundation For Mental Hygiene, Inc. | Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
EP0713392A1 (en) * | 1994-05-11 | 1996-05-29 | P.N. Gerolymatos S.A. | Use of clioquinol for treating helicobacter, including h. pylori, infections and related diseases |
US5505958A (en) * | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
-
1997
- 1997-08-08 BR BR9711194-5A patent/BR9711194A/pt not_active Application Discontinuation
- 1997-08-08 KR KR10-1999-7001196A patent/KR100489969B1/ko not_active IP Right Cessation
- 1997-08-08 TR TR1999/00293T patent/TR199900293T2/xx unknown
- 1997-08-08 WO PCT/IB1997/000983 patent/WO1998006403A1/en active IP Right Grant
- 1997-08-08 AU AU36324/97A patent/AU720643B2/en not_active Ceased
- 1997-08-08 CN CN97197919A patent/CN1114407C/zh not_active Expired - Fee Related
- 1997-08-08 SK SK179-99A patent/SK283117B6/sk not_active IP Right Cessation
- 1997-08-08 RU RU99105213/14A patent/RU2193406C2/ru not_active IP Right Cessation
- 1997-08-08 PL PL97331822A patent/PL188838B1/pl not_active IP Right Cessation
- 1997-08-08 JP JP10509541A patent/JP2000516606A/ja active Pending
- 1997-08-08 DK DK97932969T patent/DK0959888T3/da active
- 1997-08-08 SI SI9730230T patent/SI0959888T1/xx unknown
- 1997-08-08 CZ CZ2003491A patent/CZ295118B6/cs not_active IP Right Cessation
- 1997-08-08 AT AT97932969T patent/ATE205086T1/de not_active IP Right Cessation
- 1997-08-08 NZ NZ334124A patent/NZ334124A/xx unknown
- 1997-08-08 EP EP97932969A patent/EP0959888B1/en not_active Expired - Lifetime
- 1997-08-08 IL IL12841697A patent/IL128416A/en not_active IP Right Cessation
- 1997-08-08 CA CA002264097A patent/CA2264097C/en not_active Expired - Fee Related
- 1997-08-08 HU HU9903906A patent/HUP9903906A3/hu unknown
- 1997-08-08 PT PT97932969T patent/PT959888E/pt unknown
- 1997-08-08 ES ES97932969T patent/ES2162319T3/es not_active Expired - Lifetime
- 1997-08-08 DE DE69706566T patent/DE69706566T2/de not_active Expired - Lifetime
- 1997-08-08 CZ CZ1999484A patent/CZ292411B6/cs not_active IP Right Cessation
-
1998
- 1998-02-13 US US09/023,544 patent/US6001852A/en not_active Expired - Lifetime
-
1999
- 1999-02-09 NO NO19990595A patent/NO316768B1/no not_active Application Discontinuation
- 1999-02-10 IS IS4972A patent/IS1907B/is unknown
-
2000
- 2000-03-16 HK HK00101601A patent/HK1022437A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1022437A1 (en) | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
BG102999A (en) | New 2,3-diasubstituted-4-(3h)-quinazolinons | |
HUP0000558A3 (en) | Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
GB9103764D0 (en) | Compositions | |
IL134263A0 (en) | Use of phanquinone for the treatment of alzheimer's disease | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
DK0583026T3 (ru) | ||
BG102667A (en) | Diosgenine-containing composition | |
IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
AUPP823999A0 (en) | A treatment | |
UA29461C2 (ru) | Средство для лечения амилоидоза, способ лечения амилоидоза | |
HUP9802536A3 (en) | Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer | |
NZ268039A (en) | Use of efaroxan in treating parkinson's disease | |
MX9709684A (es) | Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. |